Loading...
Romosozumab: A Novel Agent in the Treatment for Postmenopausal Osteoporosis
Objective: To review the safety and efficacy of romosozumab (Evenity) in the treatment of osteoporosis in women. Data Sources: An English-language search of PubMed and Medline (1966 to August 2020) was conducted using the keywords romosozumab, sclerostin inhibitor, AMG785, and osteoporosis. Manufact...
Na minha lista:
| Udgivet i: | J Pharm Technol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7809324/ https://ncbi.nlm.nih.gov/pubmed/34752536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122520967632 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|